Short-Chain Fatty Acids Regulate Secretion of IL-8 from Human Intestinal Epithelial Cell Lines in vitro

Immunological Investigations

Volumn 44, Issue 7, 2015, Pages 678-693

  Asarat, M ^a,b   Vasiljevic, T ^a   Apostolopoulos, V ^a   Donkor, O ^a  

^a VICTORIA UNIVERSITY   (Australia)

^b UNIVERSITY OF TRIPOLI   (Libyan Arab Jamahiriya)

Author keywords

HT 29 cell line; interleukin 8; intestinal epithelial cells; short chain fatty acids; T4056 cell line

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 8; MESSENGER RNA; PROPIONIC ACID; SHORT CHAIN FATTY ACID; VOLATILE FATTY ACID;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CLINICAL EVALUATION; COCULTURE; CONCENTRATION PROCESS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; DOWN REGULATION; DRUG MECHANISM; HT 29 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE EPITHELIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; CELL LINE; CELL SURVIVAL; DRUG EFFECTS; EPITHELIUM CELL; GENE EXPRESSION; GENETICS; INTESTINE MUCOSA; METABOLISM; SECRETION (PROCESS);

CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; EPITHELIAL CELLS; FATTY ACIDS, VOLATILE; GENE EXPRESSION; HUMANS; INTERLEUKIN-8; INTESTINAL MUCOSA; RNA, MESSENGER;

EID: 84943264359     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2015.1085389     Document Type: Article

References (81)

1. Alpan O. (2001). Oral tolerance and gut-oriented immune response to dietary proteins. Curr Allergy Asthma Rep, 1, 572-7.
2. American Type Culture Collection (ATCC). USA. (2014). Available from: http://www.atcc.org/products/all/HTB-38.aspx#culturemethod 2014), vol. 2014.
3. Andoh A, Fujiyama Y, Hata K, et al. (1999). Counter-regulatory effect of sodium butyrate on tumour necrosis factor-alpha (TNF-alpha)-induced complement C3 and factor B biosynthesis in human intestinal epithelial cells. Clin Exp Immunol, 118, 23-9.
4. Angrisano T, Pero R, Peluso S, et al. (2010). LPS-induced IL-8 activation in human intestinal epithelial cells is accompanied by specific histone H3 acetylation and methylation changes. BMC Microbiol, 10, 1-8.
5. Applied Biological Materials Inc. (ABM). Canada. Available from: http://www.abmgood.com/Colon-Cells-T4056.html 2014).
6. Baggiolini M, Clark-Lewis I. (1992). Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett, 307, 97-101.
7. Bocker U, Nebe T, Herweck F, et al. (2003). Butyrate modulates intestinal epithelial cell-mediated neutrophil migration. Clin Exp Immunol, 131, 53-60.
8. Brown Z, Strieter RM, Chensue SW, et al. (1991). Cytokine-activated human mesangial cells generate the neutrophil chemoattractant, interleukin 8. Kidney Int, 40, 86-90.
9. Bultman SJ. (2013). Molecular pathways: Gene-environment interactions regulating dietary fiber induction of proliferation and apoptosis via butyrate for cancer prevention. Clin Cancer Res, 20, 799-803.
10. Burgess DJ. (2012). Metabolism: Warburg behind the butyrate paradox? Nat Rev Cancer, 12, 798-9.
11. Campbell LM, Maxwell PJ, Waugh DJ. (2013). Rationale and means to target pro-inflammatory interleukin-8 (CXCL8) signaling in cancer. Pharmaceuticals, 6, 929-59.
12. Campeau JL, Salim SY, Albert EJ, et al. (2012). Intestinal epithelial cells modulate antigen-presenting cell responses to bacterial DNA. Infect Immun, 80, 2632-44.
13. Cavaglieri CR, Nishiyama A, Fernandes LC, et al. (2003). Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes. Life Sci, 73, 1683-90.
14. Cui GB, An JZ, Zhang N, et al. (2012). Elevated interleukin-8 enhances prefrontal synaptic transmission in mice with persistent inflammatory pain. Mol Pain, 8 (11), 1-7.
15. Cummings JH, Pomare EW, Branch WJ, et al. (1987). Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut, 28, 1221-7.
16. Daig R, Rogler G, Aschenbrenner E, et al. (2000). Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6. Gut, 46, 350-8.
17. Donohoe DR, Collins LB, Wali A, et al. (2012). The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol Cell, 48, 612-16.
18. Dotan I, Mayer L. (2002). Immunopathogenesis of inflammatory bowel disease. Curr Opin Gastroenterol, 18, 421-7.
19. Fusunyan RD, Quinn JJ, Fujimoto M, et al. (1999). Butyrate switches the pattern of chemokine secretion by intestinal epithelial cells through histone acetylation. Mol Med, 5, 631-40.
20. Fusunyan RD, Quinn JJ, Ohno Y, et al. (1998). Butyrate enhances interleukin (IL)-8 secretion by intestinal epithelial cells in response to IL-1beta and lipopolysaccharide. Pediatr Res, 43, 84-90.
21. Galli C, Calder PC. (2009). Effects of fat and fatty acid intake on inflammatory and immune responses: A critical review. Ann Nutr Metab, 55, 123-139.
22. Gallicchio M, Rosa AC, Dianzani C, et al. (2008). Celecoxib decreases expression of the adhesion molecules ICAM-1 and VCAM-1 in a colon cancer cell line (HT29). Br J Pharmacol, 153, 870-8.
23. Gibson P, Rosella O. (1995). Interleukin 8 secretion by colonic crypt cells in vitro: Response to injury suppressed by butyrate and enhanced in inflammatory bowel disease. Gut, 37, 536-43.
24. Hague A, Manning AM, Hanlon KA, et al. (1993). Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: Implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer, 55, 498-505.
25. Hijova E, Chmelarova A. (2007). Short chain fatty acids and colonic health. Bratisl Med J, 108, 354-8.
26. Hinnebusch BF, Meng S, Wu JT, et al. (2002). The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr, 132, 1012-17.
27. Huang N, Katz JP, Martin DR, Wu GD. (1997). Inhibition of IL-8 gene expression in Caco-2 cells by compounds which induce histone hyperacetylation. Cytokine, 9, 27-36.
28. Huang N, Wu GD. (1997). Short chain fatty acids inhibit the expression of the neutrophil chemoattractant, interleukin 8, in the Caco-2 intestinal cell line. In: Kritchevsky D., Bonfield C. (ed.), Dietary fiber in health and disease, pp. 145-153. New York: Springer, Plenum Press.
29. Jha HC, Srivastava P, Prasad J, Mittal A. (2011). Chlamydia pneumoniae heat shock protein 60 enhances expression of ERK, TLR-4 and IL-8 in atheromatous plaques of coronary artery disease patients. Immunol Invest, 40, 206-22.
30. Kayama H, Takeda K. (2012). Regulation of intestinal homeostasis by innate and adaptive immunity. Int Immunol, 24, 673-80.
31. Kiefer J, Beyer-Sehlmeyer G, Pool-Zobel BL. (2006). Mixtures of SCFA, composed according to physiologically available concentrations in the gut lumen, modulate histone acetylation in human HT29 colon cancer cells. Br J Nutr, 96, 803-10.
32. Kolios G, Robertson DA, Jordan NJ, et al. (1996). Interleukin-8 production by the human colon epithelial cell line HT-29: Modulation by interleukin-13. Br J Pharmacol, 119, 351-9.
33. Kosiewicz MM, Zirnheld AL, Alard P. (2011). Gut microbiota, immunity, and disease: A complex relationship. Front Microbiol, 2 (180), 1-11.
34. Lee KE, Khoi PN, Xia Y, et al. (2013). Helicobacter pylori and interleukin-8 in gastric cancer. World J Gastroenterol, 19, 8192-202.
35. Lee YS, Choi I, Ning Y, et al. (2012). Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis. Br J Cancer, 106, 1833-41.
36. Leung CH, Lam W, Ma DL, et al. (2009). Butyrate mediates nucleotide-binding and oligomerisation domain (NOD) 2-dependent mucosal immune responses against peptidoglycan. Eur J Immunol, 39, 3529-37.
37. Li A, Varney ML, Singh RK. (2001). Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin Cancer Res, 7, 3298-304.
38. Licciardi PV, Ververis K, Karagiannis TC. (2011). Histone deacetylase inhibition and dietary short-chain fatty acids. ISRN Allergy, 2011 (8), 1-8.
39. Mahida YR, Johal S. (2001). NF-kappa B may determine whether epithelial cell-Microbial interactions in the intestine are hostile or friendly. Clin Exp Immunol, 123, 347-9.
40. Malago JJ, Koninkx JF, Tooten PC, et al. (2005). Anti-inflammatory properties of heat shock protein 70 and butyrate on Salmonella -induced interleukin-8 secretion in enterocyte-like Caco-2 cells. Clin Exp Immunol, 141, 62-71.
41. Maslowski KM, Vieira AT, Ng A, et al. (2009). Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature, 461, 1282-6.
42. Matthews GM, Howarth GS, Butler RN. (2012). Short-chain fatty acids induce apoptosis in colon cancer cells associated with changes to intracellular redox state and glucose metabolism. Chemotherapy, 58, 102-9.
43. Mirmonsef P, Zariffard MR, Gilbert D, et al. (2012). Short-chain fatty acids induce pro-inflammatory cytokine production alone and in combination with toll-like receptor ligands. Am J Reprod Immunol, 67, 391-400.
44. Mitsuyama K, Toyonaga A, Sasaki E, et al. (1994). IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease. Clin Exp Immunol, 96, 432-6.
45. Morsy MM, El Mahdy MIE, Helmy WHA. (2001). Interleukin-8 and Soluble intercellular adhesion molecule-1 in patients with ulcerative colitis. Egyptian J Hosp Med, 5, 1-11.
46. Ning Y, Lenz HJ. (2012). Targeting IL-8 in colorectal cancer. Exp Opin Ther Targets, 16, 491-7.
47. Okamoto T, Okabe S. (2000). Ultraviolet absorbance at 260 and 280 nm in RNA measurement is dependent on measurement solution. Int J Mol Med, 5, 657-9.
48. Pang G, Xie J, Chen Q, Hu Z. (2012). How functional foods play critical roles in human health. Food Sci Human Wellness, 1, 26-60.
49. Pastorelli L, de Salvo C, Mercado JR, et al. (2013). Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: Lessons learned from animal models and human genetics. Front Immunol, 4 (280), 1-22.
50. Payne AN, Chassard C, Zimmermann M, et al. (2011). The metabolic activity of gut microbiota in obese children is increased compared with normal-weight children and exhibits more exhaustive substrate utilization. Nutr Diabetes, 1, e12.
51. Peterson LW, Artis D. (2014). Intestinal epithelial cells: Regulators of barrier function and immune homeostasis. Nat Rev Immunol, 14, 141-53.
52. Rogler G, Andus T. (1998). Cytokines in inflammatory bowel disease. World J Surg, 22, 382-9.
53. Roy CC, Kien CL, Bouthillier L, Levy E. (2006). Short-chain fatty acids: Ready for prime time? Nutr Clin Pract, 21, 351-366.
54. Saemann MD, Bohmig GA, Osterreicher CH, et al. (2000). Anti-inflammatory effects of sodium butyrate on human monocytes: Potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB J, 14, 2380-2.
55. Salminen S, Bouley C, Boutron MC, et al. (1998). Functional food science and gastrointestinal physiology and function. Br J Nutr, 80, S147-71.
56. Sanderson IR. (2007). Dietary Modulation of GALT. J Nutr, 137, 2557S-62S.
57. Schilderink R, Verseijden C, de Jonge WJ. (2013). Dietary inhibitors of histone deacetylases in intestinal immunity and homeostasis. Front Immunol, 4 (226), 1-7.
58. Schuerer-Maly CC, Eckmann L, Kagnoff MF, et al. (1994). Colonic epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharide. Immunol, 81, 85-91.
59. Sitaraman SV, Merlin D, Wang L, et al. (2001). Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6. J Clin Invest, 107, 861-9.
60. Skov L, Beurskens FJ, Zachariae CO, et al. (2008). IL-8 as antibody therapeutic target in inflammatory diseases: Reduction of clinical activity in palmoplantar pustulosis. J Immunol, 181, 669-79.
61. Soliman A, Michelsen KS, Karahashi H, et al. (2010). Platelet-activating factor induces TLR4 expression in intestinal epithelial cells: Implication for the pathogenesis of necrotizing enterocolitis. PLoS One, 5, e15044.
62. Stadnyk AW. (2002). Intestinal epithelial cells as a source of inflammatory cytokines and chemokines. Can J Gastroenterol, 16, 241-6.
63. Strieter RM, Phan SH, Showell HJ, et al. (1989). Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts. J Biol Chem, 264, 10621-6.
64. Sun S, Li W, Zhang H, et al. (2012). Requirement for store-operated calcium entry in sodium butyrate-induced apoptosis in human colon cancer cells. Bioscience Rep, 32, 83-90.
65. Suzuki M, Hisamatsu T, Podolsky DK. (2003). Gamma interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular toll-like receptor 4-MD-2 complex. Infect Immun, 71, 3503-11.
66. Tedelind S, Westberg F, Kjerrulf M, Vidal A. (2007). Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: A study with relevance to inflammatory bowel disease. World J Gastroenterol, 13, 2826-32.
67. Thorley AJ, Ford PA, Giembycz MA, et al. (2007). Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages. J Immunol, 178, 463-73.
68. Treem WR, Ahsan N, Shoup M, Hyams JS. (1994). Fecal short-chain fatty acids in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr, 18, 159-64.
69. Ueda T, Shimada E, Urakawa T. (1994). Serum levels of cytokines in patients with colorectal cancer: Possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis. J Gastroenterol, 29, 423-9.
70. Ustunol Z, Wong C. (2010). Effect of nonfat dry milk and major whey components on interleukin-6 and interleukin-8 production in human intestinal epithelial-like Caco-2 cells. J Dairy Sci, 93, 2311-14.
71. Vinolo MA, Rodrigues HG, Nachbar RT, Curi R. (2011). Regulation of inflammation by short chain fatty acids. Nutrients 3, 858-76.
72. Wachtershauser A, Stein J. (2000). Rationale for the luminal provision of butyrate in intestinal diseases. Eur J Nutr, 39, 164-71.
73. Waugh DJ, Wilson C. (2008). The interleukin-8 pathway in cancer. Clin Cancer Res, 14, 6735-41.
74. Weber TE, Kerr BJ. (2006). Butyrate differentially regulates cytokines and proliferation in porcine peripheral blood mononuclear cells. Vet Immunol Immunopathol, 113, 139-47.
75. Weng M, Walker WA, Sanderson IR. (2007). Butyrate regulates the expression of pathogen-triggered IL-8 in intestinal epithelia. Pediatr Res, 62, 542-6.
76. Wood C, Keeling S, Bradley S, et al. (2007). Interactions in the mucosal microenvironment: Vasoactive intestinal peptide modulates the down-regulatory action of Lactobacillus rhamnosus on LPS-induced interleukin-8 production by intestinal epithelial cells. Microb Ecol Health D, 19, 191-200.
77. Wright KL, Weaver SA, Patel K, et al. (2004). Differential regulation of prostaglandin E biosynthesis by interferon-gamma in colonic epithelial cells. Br J Pharmacol, 141, 1091-7.
78. Wu S, Li RW, Li W, Li C-J. (2012). Transcriptome characterization by RNA-seq unravels the mechanisms of butyrate-induced epigenomic regulation in bovine cells. PLoS One, 7, e36940.
79. Yang XD, Corvalan JR, Wang P, et al. (1999). Fully human anti-interleukin-8 monoclonal antibodies: Potential therapeutics for the treatment of inflammatory disease states. J Leukoc Biol, 66, 401-10.
80. Yomogida S, Hua J, Sakamoto K, Nagaoka I. (2008). Glucosamine suppresses interleukin-8 production and ICAM-1 expression by TNF-alpha-stimulated human colonic epithelial HT-29 cells. Int J Mol Med, 22, 205-11.
81. Zheng J, Meng J, Zhao S, et al. (2008). Campylobacter-induced interleukin-8 secretion in polarized human intestinal epithelial cells requires Campylobacter-secreted cytolethal distending toxin- and Toll-like receptor-mediated activation of NF-kappaB. Infect Immun, 76, 4498-508